Cost of Tecfidera at a Glance
Tecfidera (dimethyl fumarate) is an oral disease-modifying therapy for relapsing forms of multiple sclerosis. The cost of Tecfidera varies widely depending on insurance, pharmacy, and location. In the United States, the average cash price for a 30-day supply of Tecfidera 240 mg twice daily typically ranges from roughly $6,500 to over $7,500, though published estimates fluctuate. This high baseline cost makes understanding coverage and assistance options essential for most patients.
More from this site
Keep reading the latest coverage
The price reflects the value placed on reducing relapse frequency and slowing disability progression, but it also creates real access challenges. Knowing where to look for help can meaningfully lower out-of-pocket expenses.
Factors That Influence the Cost of Tecfidera
Several factors shape what a patient actually pays:
- Insurance plan type: Medicare, commercial, and Medicaid plans negotiate different rates and impose different formularies and tier placements.
- Pharmacy choice: Prices can differ between retail chains, specialty pharmacies, and online mail-order services.
- Dosage and formulation: Tecfidera is available as delayed-release capsules in 240 mg strength, taken twice daily, which affects the quantity dispensed per month.
- Geographic location: Pharmacy pricing and regional reimbursement rates vary.
- Manufacturer discounts and coupons: Biogen, the manufacturer, offers programs that can significantly reduce the immediate cost.
Insurance Coverage and Typical Copays
Most private and employer-sponsored plans list Tecfidera on a specialty tier, often Tier 3 or Tier 4. Under these tiers, patients commonly face coinsurance of 20% to 33% of the negotiated price, which can still translate to hundreds of dollars per fill. Some plans apply a flat copay for specialty medications, typically ranging from $100 to $300 per month, but this depends entirely on the specific policy.
Medicare Part D plans cover Tecfidera, but patients may enter the coverage gap, often called the donut hole, where costs increase until catastrophic coverage begins. Medicare patients should check their plan's formulary and preferred pharmacy network before starting treatment.
Manufacturer Copay and Patient Assistance Programs
Biogen offers a copay card for eligible commercially insured patients that can lower the cost of Tecfidera to as little as $5 or $10 per month, depending on the plan. Patients without insurance or those whose insurance denies coverage may qualify for Biogen's patient assistance program, which provides the medication at no cost under specific income and eligibility criteria.
Key points about these programs:
- Eligibility is typically limited to U.S. residents.
- Copay cards generally cannot be used alongside government-funded insurance like Medicare or Medicaid.
- Applications require a valid prescription and proof of income or insurance status.
Comparing Tecfidera to Other MS Therapies
The cost of Tecfidera places it in the upper range of oral disease-modifying therapies, but it is generally less expensive than some newer monoclonal antibodies such as ocrelizumab or natalizumab. Generic or alternative therapies at different price points may be available depending on a patient's treatment history and insurance formulary. A comparison should include not only the medication price but also monitoring requirements, frequency of dosing, and overall budget impact.
| Factor | Tecfidera | Context |
|---|---|---|
| Approximate US cash price (30 days) | $6,500–$7,500 | Varies by pharmacy and region |
| Typical insurance tier | Specialty Tier 3 or 4 | Determines coinsurance or copay |
| Manufacturer copay card | As low as $5/month | For commercially insured patients |
| Patient assistance eligibility | Income and insurance criteria | Uninsured or underinsured patients |
Strategies to Reduce the Cost of Tecfidera
Patients facing high out-of-pocket costs can take several concrete steps. First, confirm that the pharmacy is in-network and check for price differences using pharmacy comparison tools. Second, apply for the Biogen copay card or patient assistance program early, before facing a denial or a large bill. Third, ask the prescribing clinician about therapeutic alternatives that may be equally effective but lower in cost if insurance coverage is limited. Finally, some specialty pharmacies offer additional discount programs or loyalty pricing that can further reduce the cost of Tecfidera.
Bottom Line
The cost of Tecfidera is substantial, but a combination of insurance coverage, manufacturer assistance, and proactive pharmacy shopping can make the treatment more affordable. Patients should work closely with their healthcare team and insurance navigator to understand their specific financial responsibility before starting therapy.